Literature DB >> 29459427

Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question.

Kevin L Winthrop1, John W Baddley2.   

Abstract

Entities:  

Keywords:  corticosteroids; infections; rheumatoid arthritis

Mesh：

Substances：

Year:  2018        PMID： 29459427     DOI： 10.1136/annrheumdis-2017-212588

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  Pneumocystis jiroveci pneumonia prophylaxis in patients with autoimmune hepatitis.

Authors:  Patrick Stauffer; Joseph Ahn
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-07-22

2.  Atypical presentation of Pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis treated with tofacitinib: a case presentation.

Authors:  Ian F J Pirker; Jacqueline Krane-Nuber; Werner C Albrich; Rüdiger Müller; Thomas Neumann
Journal:  BMC Rheumatol       Date:  2018-11-03

3.  Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study.

Authors:  Jin-Hua Chen; Chi-Ching Chang; Hui-Ching Hsu; Yu-Sheng Chang; Tsung-Yun Hou; Lung-Fang Chen; Li-Fang Hu; Tzu-Min Lin; Chi-Sheng Chiou; Kai-Len Tsai; Sheng-Hong Lin; Pei-I Kuo; Wei-Sheng Chen; Yi-Chun Lin
Journal:  Clin Rheumatol       Date:  2021-03-01       Impact factor: 2.980

4.  Estimation of treatment and prognostic factors of pneumocystis pneumonia in patients with connective tissue diseases.

Authors:  Yuichi Ishikawa; Kazuhisa Nakano; Kei Tokutsu; Hiroko Miyata; Yoshihisa Fujino; Shinya Matsuda; Yoshiya Tanaka
Journal:  RMD Open       Date:  2021-03

Review 5.  Pneumocystis jirovecii Pneumonia and Other Infections in Idiopathic Inflammatory Myositis.

Authors:  Christopher A Mecoli; Sonye K Danoff
Journal:  Curr Rheumatol Rep       Date:  2020-02-05       Impact factor: 4.686

6.  Practice Patterns of Pneumocystis Pneumonia Prophylaxis in Connective Tissue Diseases: A Survey of Infectious Disease Physicians.

Authors:  Rachel M Wolfe; Susan E Beekmann; Philip M Polgreen; Kevin L Winthrop; James E Peacock
Journal:  Open Forum Infect Dis       Date:  2019-07-12       Impact factor: 3.835
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.